Section outline

  • Lecture:  De-Identified Clinical Data Warehouse and the Observational Medical Outcomes Partnership

    Faculty: Eugenia Rutenberg

    • Lecture Slides: De-ID CDW and the OMOP 


    • Lecture Audio/Video Recording (Access restricted to registered students): De-ID CDW and OMOP

       

    • Large Group Discussion (Access restricted to registered students): Brief formal review of lecture followed by question and answer discussion. The recorded lecture should be viewed prior to this session.

      Zoom: https://ucsf.zoom.us/my/william.brown

      Due: Results

      Results

      • Selection of sources of evidence - Give numbers of sources of evidence screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally using a flow diagram.
      • Characteristics of sources of evidence - For each source of evidence, present characteristics for which data were charted and provide the citations.
      • Critical appraisal within sources of evidence - If done, present data on critical appraisal of included sources of evidence (see item 12 in the methods section of the PRISMA-ScR checklist).
      • Results of individual sources of evidence - For each included source of evidence, present the relevant data that were charted that relate to the review questions and objectives.
      • Synthesis of results - Summarize and/or present the charting results as they relate to the review questions and objectives.
      • Risk of bias across studies - Not applicable for scoping reviews.
      • Additional analyses - Not applicable for scoping reviews.